Heart failure has become a worldwide epidemic of the 21st century with increasing impact on healthcare systems. The 2012 ESC and 2013 ACCF/ AHA guidelines have set the stage forcurrent therapy to reduce mortality and morbidity. There is a dawnof hope for therapyof acute and diastolic heart failure; it has become clearer that patients benefit from mitral reconstruction and which patients benefit from heart failure management programmes; genetics and proteomics advance in great strides; competing concepts of cell therapy seem to spiral, hopefully upwards; and we can further nurture our hope for evidence-based individualized diagnostic and therapy
Chronic heart failure continues to represent a major problem for the healthcare systems worldwide, ...
This article updates the Heart Failure Association of the European Society of Cardiology (ESC) 2007 ...
Management of heart failure is one of the most important challenges of modern medicine. Heart failur...
Heart failure has become a worldwide epidemic of the 21st century with increasing impact on healthca...
Heart failure has become a worldwide epidemic of the 21st century with increasing impact on healthca...
2012 there were a number of important advances within the clinical arena of heart failure. Recent ne...
The past year has brought many new concepts and an abundance of new data on the nature, management, ...
Heart failure has become the cardiovascular epidemic of the century. The European Journal of Heart F...
The world of cardiology continues to evolve at a rapid pace. Novel treatments are continually being ...
In the year 2021, the universal definition and classification of heart failure (HF) was published th...
Significant advances have been made in 2021 in the areas of interventional cardiology, heart failure...
Almanac 2012, cell therapy in cardiovascular disease: the national society journals present selected...
Countries with developed economies are currently facing an epidemic of heart failure (HF) and the pr...
This editorial refers to ‘Autologous CD1331 bone marrow cells and bypass grafting for regeneration o...
Major changes have occurred in these last years in heart failure (HF) management. Landmark trials an...
Chronic heart failure continues to represent a major problem for the healthcare systems worldwide, ...
This article updates the Heart Failure Association of the European Society of Cardiology (ESC) 2007 ...
Management of heart failure is one of the most important challenges of modern medicine. Heart failur...
Heart failure has become a worldwide epidemic of the 21st century with increasing impact on healthca...
Heart failure has become a worldwide epidemic of the 21st century with increasing impact on healthca...
2012 there were a number of important advances within the clinical arena of heart failure. Recent ne...
The past year has brought many new concepts and an abundance of new data on the nature, management, ...
Heart failure has become the cardiovascular epidemic of the century. The European Journal of Heart F...
The world of cardiology continues to evolve at a rapid pace. Novel treatments are continually being ...
In the year 2021, the universal definition and classification of heart failure (HF) was published th...
Significant advances have been made in 2021 in the areas of interventional cardiology, heart failure...
Almanac 2012, cell therapy in cardiovascular disease: the national society journals present selected...
Countries with developed economies are currently facing an epidemic of heart failure (HF) and the pr...
This editorial refers to ‘Autologous CD1331 bone marrow cells and bypass grafting for regeneration o...
Major changes have occurred in these last years in heart failure (HF) management. Landmark trials an...
Chronic heart failure continues to represent a major problem for the healthcare systems worldwide, ...
This article updates the Heart Failure Association of the European Society of Cardiology (ESC) 2007 ...
Management of heart failure is one of the most important challenges of modern medicine. Heart failur...